Web Analytics
Uniqure linkedin

Uniqure linkedin

uniQure | LinkedIn

Kathir Swamy - Head of Global Quality - uniQure | LinkedIn

Lauren Glenn - Director Clinical Operations - uniQure | LinkedIn

Gary McCullough - Facilities Manager - uniQure | LinkedIn

Scott McMillan - Chief Operating Officer - uniQure | LinkedIn

Robert Gut MD, PhD - Chief Medical Officer \u0026 Member of the Board of ...

Brandon Pitre - Manufacturing III - uniQure | LinkedIn

Jacek Lubelski - VP, Global Pharmaceutical Development - uniQure ...

Pierre Richard Chery - Manufacturing Sr. Specialist - uniQure | LinkedIn

Matthew Kapusta - Chief Executive Officer - uniQure | LinkedIn

uniQure | LinkedIn

Lauren Glenn - Director Clinical Operations - uniQure | LinkedIn

With its launch fizzling out, UniQure gives up on $1M+ gene therapy ...

UniQure\u0027s hemophilia B gene therapy clears another clinical test ...

UniQure CEO quits after 9 months in the job | FierceBiotech

Matt Kapusta named CEO of gene therapy pioneer UniQure, its third ...

Tanja Smolenaars - Accounts Payable Associate - uniQure | LinkedIn

Tami Kirkpatrick - Executive Assistant - uniQure, Inc. | LinkedIn

Matthew Centanni - Senior CQV/Quality Consultant - DPS Group Global ...

Seeking cost savings, uniQure cuts R\u0026D staff and trims pipeline ...

Hemophilia B Therapy AMT-061 Effective 6 Months After 1 Dose ...

Here\u0027s how to customize the URL to your LinkedIn Company Page... and ...

At uniQure, changes at the top signal preparation for US expansion

The world\u0027s most pricey drugs, from a $1.2M gene therapy to a $450K ...

Chardan\u0027s Top Pick For 2018: Gene Therapy Firm Uniqure (NASDAQ:QURE ...

Ex-uniQure chief Aldag takes helm at vaccine upstart Hookipa ...

Who\u0027s the next Big Pharma takeout target? Biogen, uniQure, AZ top ...

Production begins at uniQure MA plant to support gene therapy pipeline

Shire cans Baxalta hemophilia B gene therapy, thinning field for ...

uniQure\u0027s Hemophilia B Gene Therapy AMT-060 Shows Long-term Efficacy

uniQure Receives FDA Fast Track Designation for AMT-130 - European ...

UniQure, chasing Spark-level FIX activity, tweaks hemophilia B gene ...

Neurology Reviews - NR Gene Therapy Suppl 0319 - page S1

Hemophilia B Gene Therapy AMT-061 to Advance to Clinical Trial in 2018

EuroBiotech Report\u2014Lilly, CureVac in $1.8B deal, Brexit hits ...

Jobs with uniQure

Evolution Bioscience | Gene Therapy

Novel approaches to hemophilia therapy: successes and challenges ...

Can Porch.com become LinkedIn for your house? | Fortune

Evolution Executive Search | News \u0026 Analysis

Xconomy: UniQure to Yank Pioneering Gene Therapy From Market in Europe

Post «uniQure NV (QURE) Rounded a Bottom and is Surging» in blog Fan ...

uniQure Granted 2 New Patents Covering Gene Therapy Approach for ...

Gene therapy: Glybera approved by European Commission - BBC News

Achillion lures Zelenkofske from uniQure to fill CMO seat ...

Gene-Therapy Firm UniQure Said to Weigh a Sale, Partnerships - Bloomberg

uniQure, Bioverativ Unveil Positive Data for Hemophilia B and ...

Gene Therapy Market Potential Growth, Share, Demand and Analysis ...

BMS inks gene therapy deal with uniQure worth up to $2bn

Farmavriend stuwt Uniqure naar grote hoogte

UniQure\u0027s gene therapy AMT-061 looking promising mid trial - PharmaTimes

Key ALS Gene C9orf72 Silenced with uniQure Gene Therapy, Studies Show

Jobs with uniQure

Potential Hemophilia A Gene Therapy May Work Regardless of Inhibitor ...

Xconomy: LogicBio Lands $45M for Gene Therapies in Rare Pediatric ...

Frontiers | Gene Therapy Leaves a Vicious Cycle | Oncology

Post «uniQure NV (QURE) Rounded a Bottom and is Surging» in blog Fan ...

Unica helpt UniQure bij ingrijpende renovatie | Unica

Potential Huntington\u0027s Gene Therapy Being Readied for Further ...

UniQure moet verwachtingen waarmaken | BNR Nieuwsradio

Comprehensive Report on Gene Therapy Market Technological ...

Daily user estimates by uniqure IP address | Download Table

Gene therapy with adeno-associated virus vector 5\u2013human factor IX in ...

Gene Therapy Market Overview and Growth Rate Analysis 2018-2025 by ...

Roche pushes back Spark tender a third time. Will it close the deal ...

Enrollment of Hemophilia B Patients Ongoing in uniQure\u0027s Phase 3 ...

Amsterdam | UniQure kantoor: Mens centraal in nieuwe kantoor ...

Evolution Bioscience | Bio-Rad

Frontiers | Gene Therapy Leaves a Vicious Cycle | Oncology

Nieuw onderkomen voor uniQure na grondige renovatie

Gene-Therapy Firm UniQure Said to Weigh a Sale, Partnerships - Bloomberg

UniQure slides toward historic lows after its hemB gene therapy goes ...

Viral Vector Manufacturing Market Outlook 2019 \u2013 2025 : CGT Catapult ...

Are Existing HTA Requirements Inadequate for Establishing Value for P\u2026

Waarde van biotechbedrijf Uniqure op Nasdaq door de \u20ac1 mrd

Gene Therapy Company Tracking 1Q18 Updates - Marty Chilberg ...

UniQure Says It Will Not Pursue EC Marketing Renewal for Glybera ...

Translation of MicroRNA-Based Huntingtin-Lowering Therapies from ...

Daniel Leonard - Director, Global Patient Advocacy @ UniQure ...

Gene Therapy Company Tracking 1Q18 Updates - Marty Chilberg ...

New therapies for hemophilia | Blood Journal

bluebird offers instalment payments for Zynteglo gene therapy ...

Xconomy: Data Starts Stretch Run for UniQure\u0027s Upgraded Hemophilia ...

Introduction to BioMarin Hemophilia - YouTube

Treeway announces License and Collaboration Agreement with uniQure ...

Translation of MicroRNA-Based Huntingtin-Lowering Therapies from ...

25 Up-and-Coming Gene Therapies of 2019

UniQure\u0027s Therapy Enters the PRIME Scheme | Front Line Genomics

AMD and 3 more momentum stocks to watch - MarketWatch

Loop | 3rd Annual Gene Therapy for Rare Disorders

Gene therapy drugs in the pharmaceutical market and a timeline of ...

Viral Vector Manufacturing Market | MarketsandMarkets

How to build a Successful Biotech company with Joern Aldag

Prevail Therapeutics Announces Executive Team Promotion and ...

Hoofdkantoor uniQure Amsterdam \u2013 D/DOCK - De Architect

Potential Huntington\u0027s Therapy AMT-130 Wins FDA Orphan Drug Status ...

Gene Therapy Player Uniqure Could Be Acquired; Biotech Company\u0027s ...

Gene Therapy\u0027s Big Comeback

Chiesi Ends Collaboration with uniQure on Hemophilia B Gene Therapy ...

The Naked Truth: Choosing the Best Clinical Development Vendor the ...